MedPage Today4h
FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes
The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Healio4h
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Scientists uncover key mechanism linking microtubules and chemotherapy, enhancing cancer drug efficacy
A joint research team from the LKS Faculty of Medicine (HKUMed) and the Faculty of Science at the University of Hong Kong has uncovered an unexpected interaction between chemotherapeutic agents and a ...
Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
Acsh.org3d
Rare Diseases Are Neglected. The FDA Needs A Dedicated 'Center of Excellence for Rare Diseases'.
The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...
BioSpace1d
‘No Job Security’ at FDA as Trump Team Seeks to Dismantle Workforce
The White House is reportedly considering an executive order to fire thousands of HHS employees. If implemented within the ...
Inflammation-triggering cellular pathway identified as potential new drug target for Alzheimer's disease
A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...
Regeneron Pharmaceuticals, Inc.: Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.
acm.org2d
Molecular Communications in Blood Vessels: Models, Analysis, and Enabling Technologies
Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...
News Medical on MSN4d
USC-led study finds potential new drug target for Alzheimer’s disease
A team of researchers from USC has unlocked the details of a cellular pathway that triggers cellular inflammation and aging and is linked to Alzheimer’s disease, particularly among those who carry the ...
Laredo Morning Times1d
Lack of diversity in clinical trials is leaving women and patients of color behind and harming the future of medicine – Podcast
Yet, this lack of bespoke options is more or less the reality of medicine today. Despite the many biological differences between people of different genders, races, ages and life histories, chances ...